Northern Trust Corp Castle Biosciences Inc Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

A detailed history of Northern Trust Corp transactions in Castle Biosciences Inc stock. As of the latest transaction made, Northern Trust Corp holds 244,388 shares of CSTL stock, worth $5.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

244,388

Previous 249,983 2.24%

Holding current value

$5.32 Million

Previous $5.39 Million 0.35%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$18.06 - $25.3 $101,045 - $141,553	-5,595 Reduced 2.24%	244,388 $5.41 Million
Q4 2023 Feb 13, 2024	BUY	$12.19 - $22.43 $74,810 - $137,652	6,137 Added 2.52%	249,983 $5.39 Million
Q3 2023 Nov 13, 2023	BUY	$13.28 - $20.3 $89,799 - $137,268	6,762 Added 2.85%	243,846 $4.12 Million
Q2 2023 Aug 11, 2023	BUY	$11.66 - $26.0 $132,714 - $295,932	11,382 Added 5.04%	237,084 $3.25 Million
Q1 2023 May 15, 2023	SELL	$19.47 - $28.49 $85,492 - $125,099	-4,391 Reduced 1.91%	225,702 $5.13 Million

Q4 2022 Feb 13, 2023	BUY	$18.08 - $30.0 $47,459 - $78,750	2,625 Added 1.15%	230,093 $5.42 Million
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $120,135 - $183,165	5,337 Added 2.4%	227,468 $5.93 Million
Q2 2022 Aug 12, 2022	BUY	$16.0 - $45.99 $156,896 - $450,977	9,806 Added 4.62%	222,131 $4.88 Million
Q1 2022 May 13, 2022	SELL	$33.17 - $46.98 $210,198 - $297,712	-6,337 Reduced 2.9%	212,325 $9.53 Million
Q4 2021 Feb 08, 2022	SELL	$39.06 - $67.58 $192,682 - $333,372	-4,933 Reduced 2.21%	218,662 $9.37 Million
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $47,622 - $61,459	792 Added 0.36%	223,595 $14.9 Million
Q2 2021 Aug 13, 2021	BUY	$50.07 - $76.78 $2.29 Million - $3.52 Million	45,829 Added 25.9%	222,803 $16.3 Million
Q1 2021 May 12, 2021	BUY	$58.92 - $97.33 $857,403 - $1.42 Million	14,552 Added 8.96%	176,974 $12.1 Million
Q4 2020 Feb 11, 2021	BUY	$43.6 - $73.05 $353,901 - $592,946	8,117 Added 5.26%	162,422 $10.9 Million
Q3 2020 Nov 16, 2020	BUY	$38.47 - $52.03 $949,054 - $1.28 Million	24,670 Added 19.03%	154,305 $7.94 Million
Q2 2020 Aug 14, 2020	BUY	$27.28 - $43.01 $589,057 - $928,714	21,593 Added 19.99%	129,635 $4.89 Million
Q1 2020 May 14, 2020	BUY	$23.08 - $35.53 $1.19 Million - $1.83 Million	51,558 Added 91.28%	108,042 $3.22 Million
Q4 2019 Feb 14, 2020	BUY	$15.74 - $35.04 $83,217 - $185,256	5,287 Added 10.33%	56,484 $1.94 Million
Q3 2019 Nov 13, 2019	BUY	$18.09 - $27.92 $926,153 - $1.43 Million	51,197 New	51,197 $926,000

Others Institutions Holding CSTL

# of Institutions

162

Shares Held

25.3M

Call Options Held

82.2K

Put Options Held

150K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $572M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Castle Biosciences Inc Transaction History